首页/数据集/Share of insulin glargine sales Lantus vs. biosimilar US 2015-2025

Share of insulin glargine sales Lantus vs. biosimilar US 2015-2025

Statista2026-04-11 收录

生物类似药市场

胰岛素市场份额

数据链接：

https://www.statista.com/statistics/869905/percentage-lantus-sales-share-compared-to-biosimilar/数据链接链接失效反馈

官方服务：

资源简介：

Insulin glargine market share of Lantus and its U.S. biosimilar competitor between 2015 and 2025

应用场景：

相关数据集

Cetuximab Biosimilar Market

生物类似药市场

抗癌药物竞争分析

The Cetuximab Biosimilar market report offers a thorough competitive analysis, mapping key players’ strategies, market share, and business models. It provides insights into competitor dynamics, helpin

IMR REPORTS60

North America Biosimilars & Follow-on-biologics Market

生物类似药市场

后续生物制品技术

Technological advancements in the North America Biosimilars & Follow-on-biologics industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emerging techn

IMR REPORTS50

Purine Analogues Drugs Market

生物类似药市场

制药技术创新

Technological advancements in the Purine Analogues Drugs industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emerging technologies are transforming

IMR REPORTS40

Interchangeable Biosimilar Humira Market

生物类似药市场

Humira（阿达木单抗）市场分析

Global Interchangeable Biosimilar Humira Market Report 2023 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past

IMR REPORTS50

North America Biosimilars Market

生物类似药市场

医药行业竞争分析

The North America Biosimilars market report offers a thorough competitive analysis, mapping key players’ strategies, market share, and business models. It provides insights into competitor dynamics, h

IMR REPORTS40